Second quarter results 2017

Second Quarter 2018 Results


We look forward to entering a new growth phase led by our increasing focus on Speciality Care and our leadership positions in Emerging Markets and Vaccines
Olivier Brandicourt
Chief Executive Officer
Q2 2018 Results Infographic

Q2 2018 Results Infographic